India’s R&D Ecosystem: Challenges & Roadmap
News Background & Key Statistics
- Structural Shift: Private sector R&D contribution rose from 31% to 47% between 2010-11 and 2020-21, indicating expanding industry funding alongside state efforts.
- Low Overall Expenditure: India’s Gross Expenditure on R&D (GERD) stands at 0.64% of GDP, significantly below the global average of 2.7% (and South Korea’s ~4.8%).
- Publications vs Patenting: India ranks 3rd globally in S&T publications and improved from 14th to 6th in patent filings over the last decade, but commercialisation remains weak.
- Human Capital Deficit: India has only 255 researchers per million population (compared to 4,000+ in South Korea), despite churning out over 1.5 lakh PhD graduates annually.
- Concentration & Exclusion: 78% of GERD is concentrated in just five states, leaving most regions innovation-passive. Furthermore, only 5% of Indian MSMEs engage in formal R&D.
Government Initiatives for R&D
ANRF & Institutional Setup
Anusandhan National Research Foundation (2024) established with a ₹50,000 crore corpus over 5 years to seed, grow, and promote R&D across universities.
Deep-Tech Missions
National Quantum Mission (₹6,003 Cr) and IndiaAI Mission (₹10,372 Cr) focus on emerging tech frontiers, high-performance compute, and domestic AI infrastructure.
Sectoral Manufacturing Push
Semicon India Programme (₹76,000 Cr), National Biopharma Mission, and PLI schemes incentivize advanced tech adoption and domestic R&D scaling.
Regulatory & IP Reforms
Scientific Social Responsibility Policy (2020), IPR Policy reforms, and Technology Innovation Hubs (NM-ICPS) at IITs foster interdisciplinary translation.
Challenges in India’s R&D Ecosystem
Low GERD & Private Gap
Expenditure at 0.64% GDP lags global benchmarks, and private investment still focuses heavily on late-stage development over foundational research.
Brain Drain & Disconnect
Loss of top doctoral talent to foreign labs due to inadequate research environments, combined with a persistent gap between university research and industry needs.
Geographic & MSME Exclusion
Concentration of 78% GERD in 5 states leaves vast swathes innovation-absent, while 95% of MSMEs lack resources or incentives for formal R&D.
Risk Capital Deficit
Deep-tech startups struggle to secure long-horizon “patient capital”, leading to a valley of death between lab proof-of-concept and commercial deployment.
